Antimicrobial, analgesic, DPPH scavenging activities and molecular docking study of some 1,3,5-triaryl-2-pyrazolines

Medicinal Chemistry Research

Volumn 21, Issue 8, 2012, Pages 2012-2022

  Samshuddin, Seranthimata ^a   Narayana, Badiadka ^a   Sarojini, Balladka Kunhanna ^b   Khan, Mahmud Tareq Hassan ^c   Yathirajan, Hemmige S ^d   Raj, Chenna Govindaraju Darshan ^b   Raghavendra, Ramappa ^e  

^a MANGALORE UNIVERSITY   (India)

^b P A COLLEGE OF ENGINEERING   (India)

^c University of Mysore ^*  (Norway)

^d UNIVERSITY OF MYSORE   (India)

^e KUVEMPU UNIVERSITY   (India)

Author keywords

1,3,5 Triaryl 2 pyrazoline; Analgesic; Antimicrobial; DPPH scavenging assay; metRS; Molecular docking; Molecular recognition

Indexed keywords

1,1 DIPHENYL 2 PICRYLHYDRAZYL; 1,3,5 TRIPHENYL 4,5 DIHYDRO 1H PYRAZOLE; 3,5 BIS(4 BROMOPHENYL) 1 PHENYL 4,5 DIHYDRO 1H PYRAZOLE; 3,5 BIS(4 CHLOROPHENYL) 1 PHENYL 4,5 DIHYDRO 1H PYRAZOLE; 3,5 BIS(4 FLOUROPHENYL) 1 PHENYL 4,5 DIHYDRO 1H PYRAZOLE; 3,5 BIS(4 METHOXYPHENYL) 1 PHENYL 4,5 DIHYDRO 1H PYRAZOLE; 3,5 BIS(4 METHYLPHENYL) 1 PHENYL 4,5 DIHYDRO 1H PYRAZOLE; 3,5 DI(BIPHENYL 4 YL) 1 PHENYL 4,5 DIHYDRO 1H PYRAZOLE; ANALGESIC AGENT; ANTIINFECTIVE AGENT; ANTIOXIDANT; METHIONINE TRANSFER RNA LIGASE; PYRAZOLINE DERIVATIVE; UNCLASSIFIED DRUG;

ANALGESIC ACTIVITY; ANTIMICROBIAL ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CHEMICAL REACTION; DRUG SYNTHESIS; IN VITRO STUDY; INFRARED SPECTROPHOTOMETRY; MOLECULAR DOCKING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; X RAY DIFFRACTION;

EID: 84866067460     PISSN: 10542523     EISSN: 15548120     Source Type: Journal    
DOI: 10.1007/s00044-011-9735-9     Document Type: Article

References (47)

1. Abagyan RA, Totrov MM, Kuznetsov DA (1994) ICM: a new method for protein modeling and design: applications to docking and structure prediction from the distorted native conformation. J Comp Chem 15:488-506
2. Amir M, Kumar S (2005) Synthesis and anti-inflammatory, analgesic, ulcerogenic and lipid peroxidation activities of 3,5-dimethyl pyrazoles, 3-methyl pyrazol-5-ones and 3,5-disubstituted pyrazolines. Indian J Chem 44B:2532-2537
3. Amir M, Kumar H, Khan S (2008) A synthesis and pharmacological evaluation of pyrazoline derivatives as new anti-inflammatory and analgesic agents. Bioorg Med Chem Lett 18:918-922
4. Ankhiwala MD, Hathi MV (1996) Synthesis and antibacterial activity of some 1-henyl-3,5-diaryl-2-P pyrazolines. Ind J Het Chem 5:229-230
5. Azarifar D, Ghasemnejad H (2003) Microwave-assisted synthesis of some 3,5-arylated 2-yrazolines. Molecules 8:642-648
6. Bagavant G, Gole SR, Joshi VW, Soni SB (1994) Studies on antiinflammatory and analgesic activities of itaconic acid systems. Part 1: itaconoc acids and diesters. Ind J Pharm Sci 56:80-85
7. Baktir Z, Akkurt M, Samshuddin S, Narayana B, Yathirajan HS (2011) 3,5-Bis(4-methoxyphenyl)-1-henyl-4,5-dihydro-1H-yrazole. Acta Cryst E67:o328-o329
8. Butcher RJ, Akkurt M, Samshuddin S, Narayana B, Yathirajan HS (2011) 3,5-Bis(4-methylphenyl)-1-henyl-4,5-dihydro-1H-yrazole. Acta Cryst E 67:o1019
9. Fun HK, Hemamalini M, Samshuddin S, Narayana B, Yathirajan HS (2010) 1-[3,5-Bis(4-fluorophenyl)-4,5-dihydro-1H-yrazol-1-yl]ethanone. Acta Cryst E 66:o582-o583
10. Fustero S, Fuentes AS, Sanz-Cervera JF (2009) Recent advances in the synthesis of pyrazoles-a review. Org Prep Proced Int 41:253-290
11. Grosscurt AC, Hes RV, Wellnga K (1979) 1-Phenylcarbamoyl-2-yrazolines, a new class of insecticides. 3. Synthesis and insecticidal properties of 3,4-diphenyl-1-henylcarbamoyl-2-yrazolines. J Agric Food Chem 27:406-409
12. Halgren TA (1996a) Merck molecular force field. III. Molecular geometries and vibrational frequencies. J Comp Chem 17: 553-586
13. Halgren TA (1996b) Merck molecular force field. II. MMFF94 van der Waals and electrostatic parameters for intermolecular interactions. J Comp Chem 17:520-552
14. Halgren TA (1996c) Merck molecular force field. V. Extension of MMFF94 using experimental data, additional computational data and empirical rules. J Comp Chem 17:616-641
15. Halgren TA (1996d) Merck molecular force field: I. Basis, form, scope, parameterization and performance of MMFF94. J Comp Chem 17:490-519
16. Halgren TA (1999a) MMFF VI. MMFF94 s option for energy minimization studies. J Comp Chem 20:720-729
17. Halgren TA (1999b) MMFF VII. Characterization of MMFF94, MMFF94 s, and other widely available force fields for conformational energies and for intermolecular-interaction energies and geometries. J Comp Chem 20:730-748
18. Halgren TA, Nachbar RB (1996) Merck molecular force field. IV. Conformational energies and geometries for MMFF94. J Comp Chem 17:587-615
19. Harish BG, Krishna V, Sharath R, Kumara S, Raja N, Mahadevan KM (2007) Antibacterial activity of celapanin, a sesquiterpene isolated from the leaves of Celastrus paniculatus Willd. Int J Biomed Pharm Sci 1:65-68
20. Hes RV, Wellinga K, Grosscurt AC (1978) 1-Phenylcarbamoyl-2-yrazolines: a new class of insecticides. 2. Synthesis and insecticidal properties of 3,5-diphenyl-1-henylcarbamoyl-2-yrazolines. J Agric Food Chem 26:915-918
21. Hurdle JG, O'Neill AJ, Chopra I (2005) Prospects for aminoacyltRNA synthetase inhibitors as new antimicrobial agents. Antimicrob Age Chemother 49:4821-4833
22. Jasinski JP, Guild CJ, Samshuddin S, Narayana B, Yathirajan HS (2010a) 3,5-Bis(4-fluorophenyl)-1-henyl-4,5-dihydro-1H-yrazole. Acta Cryst E 66:o1948-o1949
23. Jasinski JP, Pek AE, Samshuddin S, Narayana B, Yathirajan HS (2010b) 1-[3,5-Bis(4-chlorophenyl)-4,5-dihydro-1H-yrazol-1-yl]ethanone. Acta Cryst E 66:o1950-o1951
24. Khan MT, Fuskevag OM, Sylte I (2009) Discovery of potent thermolysin inhibitors using structure based virtual screening and binding assays. J Med Chem 52:48-61
25. Klimova EI, Marcos M, Klimova TB, Cecilio AT, Ruben AT, Lena RR (1999) The structure of bicyclic ferrocenylmethylene substituted 2-yrazolines and their reactions with azodicarboxylic acid N-henylimide. J Organomet Chem 585:106-111
26. Knorr L (1893) Notiz über die pyrazolinreaction. Ber Dt Chem Ges 26:100-103
27. Kokura S, Yoshida N, Sakamoto N, Ishikawa T, Takagi T, Higashihara H, Nakabe N, Handa O, Naito Y, Yoshikawa T (2005) The radical scavenger edaravone. Cancer Lett 229:223-233
28. Lapan KA, Chapple JP, Galcheva-Gargova Z, Yang M, Tao J (2002) Peptide ligands in antibacterial drug discovery: use as inhibitors in target validation and target-based screening. Expert Opin Ther Targets 6:507-516
29. Nithitanakool S, Pithayanukul P, Bavovada R, Saparpakorn P (2009) Molecular docking studies and anti tyrosinase activity of Thai mango seed kernel extract. Molecules 14:257-265
30. Raghavendra R, Neelagund S (2009) Partial purification and biochemical characterization of antimicrobial and analgesic novel bioactive protein (substances) from Silkworm (Bombyx mori Linn.) fecal matter. Int J Bio med Pharm Sci 3:74-78
31. Rajendra Prasad Y, Lakshmana Rao A, Prasoona L, Murali K, Ravi Kumar P (2005) Synthesis and antidepressant activity of some 1,3,5-triphenyl-2- yrazolines and 3-(200-hydroxy naphthalen-100-yl)-1,5-diphenyl-2-yrazolines. Bioorg Med Chem Lett 15: 5030-5034
32. Safaei-Ghomi JH, Bamoniri A, Soltanian-Telkabadi M (2006) A modified and convenient method for the preparation of N-henylpyrazoline derivatives. Chem Het Compd 42:892-896
33. Samshuddin S, Narayana B, Yathirajan HS, Safwan AP, Tiekink ERT (2010) 3,5-Bis(4-bromophenyl)-1-henyl-4,5-dihydro-1H-yrazole. Acta Cryst E 66:o1279-o1280
34. Sarojini BK, Vidyagayatri M, Darshanraj CG, Bharath BR, Manjunatha H (2010) DPPH scavenging assay of novel 1,3-disubstituted-1H-yrazol-5-ols and their in silico studies on some proteins involved in Alzheimer's disease signaling cascade. Lett Drug Des Disc 7:214-224
35. Satyanarayana K, Rao MNA (1993) Synthesis of 3-[4-[2,3-dihydro-2- (substituted aryl)-1,5-benzothiazepin-4-yl] phenyl] sydnones as potential antiinflammatory agents. Ind J Pharm Sci 55:230-233
36. Saundane AR, Rudresh K, Satynarayana ND, Hiremath SP (1998) Pharmacological screening of 6H, 11H-indolo {3,2-C}isoquinolin-5-ones and their derivatives. Ind J Pharm Sci 60:379-383
37. Schapira M, Totrov M, Abagyan R (1999) Prediction of the binding energy for small molecules, peptides and proteins. J Mol Recog 12:177-190
38. Sharath R, Krishna V, Sathyanarayana BN, Harish B (2008) Antibacterial activity of Bacoside-A-an active constituent isolated of Bacopa monnieri (L.) Wettest. Pharmacologyonline 2:517-528
39. Sugiura I, Nureki O, Ugaji-Yoshikawa Y, Kuwabara S, Shimada A, Tateno M, Lorber B, Giege R, Moras D, Yokoyama S, Konno M (2000) The 2.0 A crystal structure of thermus thermophilus methionyl-tRNA synthetase reveals two RNA-binding modules. Structure 8:197-208
40. Taylor RD, Jewsbury PJ, Essex JW (2002) A review of protein-small molecule docking methods. J Comput Aided Mol Des 16(3): 151-166
41. Thakare VG, Wadodkar KN (1986) Synthesis of isomeric D2-yrazolines. Ind J Chem 25B:610-613
42. Tiwari AK (2004) Antioxidants: new-generation therapeutic base for treatment of polygenic disorders. Curr Sci 86:1092-1100
43. Vagdevi HM, Latha KP, Vaidya VP, Vijaya kumar ML, Pai KSR (2001) Synthesis and pharmacological screening of some Novel Naphtho [2,1-b] furo-yrazolines, isoxazoles and isoxazolines. Ind J Pharm Sci 63:286-291
44. Wallace AC, Laskowski RA, Thornton JM (1995) LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions. Protein Eng 8:127-134
45. Wei DQ, Zhang R, Du QS, Gao WN, Li Y, Gao H, Wang SQ, Zhang X, Li AX, Sirois S, Chou KC (2006) Anti-SARS drug screening by molecular docking. Amino Acids 31:73-80
46. Wiley RH, Jarboe CH, Hayes FN, Hansbury E, Nielsen JT, Callahan PX, Sellars M (1958) 1,3,5-Triaryl-2-yrazoline for use as scintillation solutes. J Org Chem 23:732-738
47. Zhang XH, Wu SK, Gao ZQ, Lee CS, Lee ST, Kwong HL (2000) Pyrazoline derivatives for blue color emitter in organic electroluminescent devices. Thin Solid Films 371:40-46